Product Description
Cochlear implant for sensorinueral hearing loss (Sourced from: https://mss-p-007-delivery.sitecorecontenthub.cloud/api/public/content/03cc45c59ef547cfa66dc72845c0961b?v=a6ad9f84&MOD=AJPERES&CVID=mlnL-Hq&useDefaultText=0&useDefaultDesc=0&CVID=mlnL-Hq)
Mechanisms of Action: No Mechanism
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: N/A
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: Cochlear
Company Location: NEW YORK NY 10271
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic: